Galactosidase, beta 1 (GLB1) (C-Term) Peptide
GLB1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5511163
Quick Overview for Galactosidase, beta 1 (GLB1) (C-Term) Peptide (ABIN5511163)
Target
GLB1
(Galactosidase, beta 1 (GLB1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- APCSSDDPEL CAVTFVDRPV IGSSVTYDHP SKPVEKRLMP PPPQKNKDSW
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- GLB1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- GLB1 (Galactosidase, beta 1 (GLB1))
-
Background
-
This gene encodes a member of the glycosyl hydrolase 35 family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature lysosomal enzyme. This enzyme catalyzes the hydrolysis of a terminal beta-linked galactose residue from ganglioside substrates and other glycoconjugates. Mutations in this gene may result in GM1-gangliosidosis and Morquio B syndrome.
Alias Symbols: EBP, ELNR1, MPS4B
Protein Size: 546 -
Gene ID
- 2720
-
NCBI Accession
- NM_000404, NP_000395
Target
-
You are here:
